P.4.10 Obesity, first-episode psychosis and lower brain gray matter volumes

2019 ◽  
Vol 29 ◽  
pp. S708
Author(s):  
M. Kolenic ◽  
J. Hlinka ◽  
F. Spaniel ◽  
T. Hajek
2020 ◽  
pp. 1-9 ◽  
Author(s):  
Daniela Hubl ◽  
Chantal Michel ◽  
Frauke Schultze-Lutter ◽  
Martinus Hauf ◽  
Benno G. Schimmelmann ◽  
...  

Abstract Background Clinical high-risk (CHR) for psychosis is indicated by ultra-high risk (UHR) and basic symptom (BS) criteria; however, conversion rates are highest when both UHR and BS criteria are fulfilled (UHR&BS). While BSs are considered the most immediate expression of neurobiological aberrations underlying the development of psychosis, research on neurobiological correlates of BS is scarce. Methods We investigated gray matter volumes (GMV) of 20 regions of interest (ROI) previously associated with UHR criteria in 90 patients from the Bern early detection service: clinical controls (CC), first-episode psychosis (FEP), UHR, BS and UHR&BS. We expected lowest GMV in FEP and UHR&BS, and highest volume in CC with UHR and BS in-between. Results Significantly, lower GMV was detected in FEP and UHR&BS patients relative to CC with no other significant between-group differences. When ROIs were analyzed separately, seven showed a significant group effect (FDR corrected), with five (inferior parietal, medial orbitofrontal, lateral occipital, middle temporal, precuneus) showing significantly lower GM volume in the FEP and/or UHR&BS groups than in the CC group (Bonferroni corrected). In the CHR group, only COGDIS scores correlated negatively with cortical volumes. Conclusions This is the first study to demonstrate that patients who fulfill both UHR and BS criteria – a population that has been associated with higher conversion rates – exhibit more severe GMV reductions relative to those who satisfy BS or UHR criteria alone. This result was mediated by the BS in the UHR&BS group, as only the severity of BS was linked to GMV reductions.


2007 ◽  
Vol 17 ◽  
pp. S92-S93
Author(s):  
J. Janssen ◽  
S. Reig ◽  
J. Sanchez ◽  
D. Moreno ◽  
M. Parellada ◽  
...  

2017 ◽  
Vol 27 (1) ◽  
pp. 113-126 ◽  
Author(s):  
Josefina Castro-Fornieles ◽  
Nuria Bargalló ◽  
Anna Calvo ◽  
Celso Arango ◽  
Immaculada Baeza ◽  
...  

NeuroImage ◽  
2001 ◽  
Vol 13 (6) ◽  
pp. 1084
Author(s):  
Katrine Pagsberg ◽  
William Baaré ◽  
Torben Mackeprang ◽  
Anne Marie Christensen ◽  
Tove Aarkrog ◽  
...  

2017 ◽  
Vol 264 ◽  
pp. 46-51 ◽  
Author(s):  
Kara Dempster ◽  
Ross Norman ◽  
Jean Théberge ◽  
Maria Densmore ◽  
Betsy Schaefer ◽  
...  

2017 ◽  
Vol 51 (5) ◽  
pp. 500-508 ◽  
Author(s):  
Bruno Dietsche ◽  
Tilo Kircher ◽  
Irina Falkenberg

Objective: Schizophrenia is a devastating mental disorder accompanied by aberrant structural brain connectivity. The question whether schizophrenia is a progressive brain disorder is yet to be resolved. Thus, it is not clear when these structural alterations occur and how they develop over time. Methods: In our selective review, we summarized recent findings from longitudinal magnetic resonance imaging studies investigating structural brain alterations and its impact on clinical outcome at different stages of the illness: (1) subjects at ultra-high risk of developing psychosis, (2) patients with a first episode psychosis, and (3) chronically ill patients. Moreover, we reviewed studies examining the longitudinal effects of medication on brain structure in patients with schizophrenia. Results: (1) Studies from pre-clinical stages to conversion showed a more pronounced cortical gray matter loss (i.e. superior temporal and inferior frontal regions) in those individuals who later made transition to psychosis. (2) Studies investigating patients with a first episode psychosis revealed a decline in multiple gray matter regions (i.e. frontal regions and thalamus) over time as well as progressive cortical thinning in the superior and inferior frontal cortex. (3) Studies focusing on patients with chronic schizophrenia showed that gray matter decreased to a greater extent (i.e. frontal and temporal areas, thalamus, and cingulate cortices)—especially in poor-outcome patients. Very few studies reported effects on white matter microstructure in the longitudinal course of the illness. Conclusion: There is adequate evidence to suggest that schizophrenia is associated with progressive gray matter abnormalities particularly during the initial stages of illness. However, causal relationships between structural changes and illness course—especially in chronically ill patients—should be interpreted with caution. Findings might be confounded by longer periods of treatment and higher doses of antipsychotics or epiphenomena related to the illness.


2018 ◽  
Vol 45 (4) ◽  
pp. 846-858 ◽  
Author(s):  
Christian Núñez ◽  
Christian Stephan-Otto ◽  
Judith Usall ◽  
Miquel Bioque ◽  
Antonio Lobo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document